Stock listing
Frankfurt:BT3 Lineage Cell Therapeutics, Inc. Aktie
German listing (Frankfurt) of Lineage Cell Therapeutics, Inc. · home listing NYSE American:LCTX
Follow Lineage Cell Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · FWB:BT3
€0.838 EUR -0.019 (-2.2%)
Close on Oct 19, 2026
- Day range
- €0.838 – €0.838 EUROct 19, 2026
- Market cap
- €211.9M EURAt the close on Oct 19, 2026 · price × 252.9M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:LCTX · Home | $0.953 USD | -0.025 (-2.6%) | 948,614 | $0.981 | $0.996 | $0.940 | $0.978 | Close on Oct 19, 2026 |
| TASE:LCTX | 300.90 ILA (agorot) | +14.70 (+5.1%) | 11,763 | 291.00 | 305.10 | 291.00 | 286.20 | Close on Oct 19, 2026 |
| Frankfurt:BT3 | €0.838 EUR | -0.019 (-2.2%) | — | €0.838 | €0.838 | €0.838 | €0.857 | Close on Oct 19, 2026 |
- Ticker
- Frankfurt:BT3
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Sep 8, 2026
Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform
Latest earnings call · Aug 6, 2026
Lineage Cell Therapeutics (NYSE American: LCTX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Sep 14, 2026
Investor Presentation (September 2026)
Investor deck · 49 slides
Calls
Replays
Lineage Cell Therapeutics (NYSE American: LCTX) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptLineage Cell Therapeutics (NYSE American: LCTX) Q1 2026 Earnings Call
Tue, May 12, 2026 · 4:30 PM ET
Watch TranscriptLineage Cell Therapeutics (NYSE American: LCTX) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Decks
Investor Presentation (September 2026)
Investor deck · 49 slides · Sep 14, 2026
Retinal Innovation Summit 2026
Conference · 22 slides · 2026
Q1 2025 Earnings Presentation
Earnings · 38 slides · May 13, 2025
Q4 2024 Earnings Presentation
Earnings · 43 slides · Mar 10, 2025
Lineage Cell Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 17 in the last 12 months · 30 in all · newest Sep 8, 2026 · oldest 2025
- Calls
- 13 calls with a replay · 13 with a transcript · latest Aug 6, 2026
- Decks
- 21 decks · latest Sep 14, 2026
Where Lineage Cell Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:LCTX · Home listing | NYSE American | United States | USD |
| TASE:LCTX | TASE | Israel | ILA |
| gettex:BT3 | gettex | Germany | EUR |
| LS Exchange:A2PP89 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PP89 | Lang & Schwarz | Germany | EUR |
| BOATS:LCTX | BOATS | United States | USD |
| Frankfurt:BT3 · This page | Frankfurt | Germany | EUR |
| Tradegate:BT3 | Tradegate | Germany | EUR |
| Dusseldorf:BT3 | Dusseldorf | Germany | EUR |
| Stuttgart:BT3 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Lineage Cell Therapeutics, Inc.